Events
NIH Technology Opportunity Webinar: Novel therapy for Retinitis Pigmentosa
Register to attend a free NIH webinar and learn about a potential novel treatment for Retinitis Pigmentosa (RP). Dr. Patricia Becerra and her team at the National Eye Institute developed a novel therapeutic pigment epithelium-derived factor (PEDF) peptide that exhibits a highly potent effect on photoreceptor protection in in vivo mouse models. Over 100,000 people …